Press Release | December 07, 2023
Press & Publications
Press
Press Release | November 06, 2023
50% Recruitment milestone reached in clinical validation study of EDIT B blood test: An aid for differential diagnosis of bipolar disorder based on RNA Editing biomarkers
Award | October 09, 2023
Finalist list of the European Lifestars Awards – Celebrating Life Science eXecutives & their partners!
Award | March 28, 2023
We won the Medical Diagnostic trophy at the 2nd edition of the “Healthtech awards” organised by France Biotech!
Press Release | March 27, 2023
ALCEDIAG and SYNLAB join forces in Europe to fight diagnostic delay of bipolar disorder with the EDIT-B™ test
News | November 18, 2022
OUEST-FRANCE À Montpellier, une start-up développe un test pour diagnostiquer la bipolarité
News | July 12, 2022
ALCEDIAG Announces the Inclusion of the First Patient in clinical validation study for EDIT-B test: an aid for differential diagnosis of bipolar disorder, based on RNA editing blood biomarkers
Scientific Publications
Translational Psychiatry | August 30, 2016
Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression
D Weissmann, S van der Laan, MD Underwood, N Salvetat, L Cavarec, L Vincent, F Molina, JJ Mann, V Arango and JF Pujol
Translational Psychiatry | August 20, 2016
In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells
D Weissmann, S van der Laan, MD Underwood, N Salvetat, L Cavarec, L Vincent, F Molina, JJ Mann, V Arango and JF Pujol